ArticleFrontiers in cardiovascular medicine2025
Changing performance of surgical risk scores according to the endpoint of postoperative mortality in infective endocarditis patients.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The optimal endpoint for reporting early mortality after cardiac operations for infective endocarditis (IE), as well as the optimal mortality target for surgical risk scores, are unresolved questions. Methods: Five risk scores created specifically to predict early mortality after cardiac operations for definite IE, and the European System for Cardiac Operative Risk Evaluation II, were assessed in terms of calibration, discrimination and accuracy in predicting early mortality following cardiac surgery for IE. The evaluation was based on five definite endpoints of postoperative mortality: In-hospital, 30-day, in-hospital/30-day, six-month, and one-year mortality. The six risk scores were tested in a population of 991 patients with definite IE who underwent 1,014 cardiac operations at five European university-affiliated centers. Results: There were 133 (13.1%) hospital deaths after surgery. Overall, 10% of patients died within 30 days after surgery, 10.4% of survivors died between 30 days and six months after surgery, and another 5.5% between six months and one year after surgery. All risk scores showed good prediction accuracy and at least acceptable discrimination for all endpoints of postoperative mortality. However, only one (IE-specific) risk score exhibited acceptable calibration for every endpoint of postoperative mortality. Conclusions: Since mortality decreases slowly throughout the first year after cardiac surgery for IE, it may be appropriate to report both in-hospital and one-year mortality (coupled endpoint) for this condition. For both endpoints, only one of the risk scores considered in this study showed acceptable calibration and discrimination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.